{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:21:38Z","timestamp":1789849298800,"version":"4.0.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,8]]},"DOI":"10.1093\/ije\/30.4.864","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:55:00Z","timestamp":1027724100000},"page":"864-871","source":"Crossref","is-referenced-by-count":47,"title":["Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts"],"prefix":"10.1093","volume":"30","author":[{"given":"Yazdan","family":"Yazdanpanah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Ch\u00eane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Losina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue J","family":"Goldie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence Dequae","family":"Merchadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Alfandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"George R","family":"Seage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Marimoutou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A David","family":"Paltiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Salamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Mouton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A","family":"Freedberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2001,8]]},"reference":[{"key":"key\n\t\t\t\t20170712063355_R1","doi-asserted-by":"crossref","unstructured":"Palella FJJ, Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med1998;338:853\u201360.","DOI":"10.1056\/NEJM199803263381301"},{"key":"key\n\t\t\t\t20170712063355_R2","doi-asserted-by":"crossref","unstructured":"Bacellar H, Munoz A, Hoover DR et al. Incidence of clinical AIDS conditions in a cohort of homosexual men with CD4+ cell counts <100\/mm3 . J Infect Dis1994;170:1284\u201387.","DOI":"10.1093\/infdis\/170.5.1284"},{"key":"key\n\t\t\t\t20170712063355_R3","doi-asserted-by":"crossref","unstructured":"Munoz A, Schrager LK, Bacellar H et al. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985\u20131991. Am J Epidemiol1993; 137:423\u201338.","DOI":"10.1093\/oxfordjournals.aje.a116691"},{"key":"key\n\t\t\t\t20170712063355_R4","doi-asserted-by":"crossref","unstructured":"Pierce M, Crampton S, Henry D et al. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. N Engl J Med1996;335:384\u201391.","DOI":"10.1056\/NEJM199608083350603"},{"key":"key\n\t\t\t\t20170712063355_R5","doi-asserted-by":"crossref","unstructured":"Schneider MM, Hoepelman AI, Eeftinck Schattenkerk JK et al. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group. N Engl J Med1992; 327:1836\u201341.","DOI":"10.1056\/NEJM199212243272603"},{"key":"key\n\t\t\t\t20170712063355_R6","doi-asserted-by":"crossref","unstructured":"Chan ISF, Neaton JD, Saravolatz LD, Crane LR, Ostreberger J. Community Programs for Clinical Research on AIDS. Frequencies of opportunistic diseases prior to death among HIV-infected persons. AIDS1995;9:1145\u201351.","DOI":"10.1097\/00002030-199510000-00005"},{"key":"key\n\t\t\t\t20170712063355_R7","doi-asserted-by":"crossref","unstructured":"Sudre P, Hirschel BJ, Gatell JM et al. Tuberculosis among European patients with the acquired immune deficiency syndrome. The AIDS in Europe Study Group. Tubercle Lung Dis1996;77:322\u201328.","DOI":"10.1016\/S0962-8479(96)90096-9"},{"key":"key\n\t\t\t\t20170712063355_R8","doi-asserted-by":"crossref","unstructured":"Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis1992;15:211\u201322.","DOI":"10.1093\/clinids\/15.2.211"},{"key":"key\n\t\t\t\t20170712063355_R9","doi-asserted-by":"crossref","unstructured":"Owens DK, Nease RF. A normative analytic framework for development of practice guidelines for specific clinical populations. Med Decis Making1997;17:409\u201326.","DOI":"10.1177\/0272989X9701700406"},{"key":"key\n\t\t\t\t20170712063355_R10","unstructured":"Anonymous. Surveillance de SIDA en France au 30 Juin 1998. Bull Epidemiol Hebdo1998;37."},{"key":"key\n\t\t\t\t20170712063355_R11","unstructured":"Dabis F, Chene G, Salamon R, Msellati B, Etcheverry B, and the Groupe d'Epid\u00e9miologie Clinique du SIDA en Aquitaine (GECSA). Hospital-based surveillance of HIV infection: Bordeaux, France, 1983\u2013 1990. AIDS1991;5:774\u201375."},{"key":"key\n\t\t\t\t20170712063355_R12","unstructured":"Marimoutou C, Chene G, Dabis F, Lacoste D, Salamon R, and the Groupe d'Epid\u00e9miologie Clinique du SIDA en Aquitaine (GECSA). HIV infection and AIDS in Aquitaine\u2014Data obtained over the last ten years with a hospital-based information system 1985\u20131995. Presse Med1997;26:703\u201310."},{"key":"key\n\t\t\t\t20170712063355_R13","doi-asserted-by":"crossref","unstructured":"Chene G, Dabis F, Salamon R, and the Groupe d'Epid\u00e9miologie Clinique du SIDA en Aquitaine. Hospital-based surveillance of HIV infection: epidemiological trends, Bordeaux, France 1983\u20131989. Eur J Epidemiol1992;8:58\u201366.","DOI":"10.1007\/BF03334973"},{"key":"key\n\t\t\t\t20170712063355_R14","doi-asserted-by":"crossref","unstructured":"Havlir DV, Dube MP, Sattler FR et al. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group. N Engl J Med1996;335:392\u201398.","DOI":"10.1056\/NEJM199608083350604"},{"key":"key\n\t\t\t\t20170712063355_R15","doi-asserted-by":"crossref","unstructured":"Hirschtick RE, Glassroth J, Jordan MC et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary complications of HIV Infection Study Group. N Engl J Med1995;333: 845\u201351.","DOI":"10.1056\/NEJM199509283331305"},{"key":"key\n\t\t\t\t20170712063355_R16","doi-asserted-by":"crossref","unstructured":"Miller DK, Homan SM. Determining transition probabilities: confusion and suggestions. Med Decis Making1994;14:52\u201358.","DOI":"10.1177\/0272989X9401400107"},{"key":"key\n\t\t\t\t20170712063355_R17","unstructured":"Diggle PJ, Liang KY, Zeger SL. Analysis of Longitudinal Data. Oxford: Oxford University Press, 1994."},{"key":"key\n\t\t\t\t20170712063355_R18","unstructured":"Cox DR. Regression models and life-tables. J Royal Stat Soc1972;124: 633\u201342."},{"key":"key\n\t\t\t\t20170712063355_R19","doi-asserted-by":"crossref","unstructured":"Furrer H, Egger M, Opravil M et al. Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-infected adults treated with combination antiretroviral therapy. N Engl J Med1999;340:1301\u201306.","DOI":"10.1056\/NEJM199904293401701"},{"key":"key\n\t\t\t\t20170712063355_R20","doi-asserted-by":"crossref","unstructured":"Burke M, Yust I, Katlama C et al. Cytomegalovirus retinitis in patients with AIDS in Europe. AIDS in Europe Study Group. Eur J Clin Microbiol Infect Dis1997;16:876\u201382.","DOI":"10.1007\/BF01700553"},{"key":"key\n\t\t\t\t20170712063355_R21","doi-asserted-by":"crossref","unstructured":"Fleming PL, Ciesielski CA, Byers RH, Castro KG, Berkelman RL. Gender differences in reported AIDS-indicative diagnoses. J Infect Dis1993;168:61\u201367.","DOI":"10.1093\/infdis\/168.1.61"},{"key":"key\n\t\t\t\t20170712063355_R22","doi-asserted-by":"crossref","unstructured":"Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. J Infect Dis1992;166:1223\u201327.","DOI":"10.1093\/infdis\/166.6.1223"},{"key":"key\n\t\t\t\t20170712063355_R23","doi-asserted-by":"crossref","unstructured":"Paltiel AD, Scharfstein JA, Seage GR III et al. A Monte Carlo simulation of advanced HIV disease: application to prevention of CMV infection. Med Decis Making1998;18Suppl.:S93\u2013105.","DOI":"10.1177\/0272989X98018002S11"},{"key":"key\n\t\t\t\t20170712063355_R24","doi-asserted-by":"crossref","unstructured":"Petito CK, Cho ES, Lemann W, Navia BA, Price RW. Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. J Neuropathol Exp Neurol1986;6:635\u201346.","DOI":"10.1097\/00005072-198611000-00003"},{"key":"key\n\t\t\t\t20170712063355_R25","doi-asserted-by":"crossref","unstructured":"Gray F, Gherardi R, Keohane C, Favolini M, Sobel A, Poirier J. Pathology of the central nervous system in 40 cases of the acquired immune deficiency syndrome (AIDS). Neuropathol Appl Neurobiol1988;14:365\u201380.","DOI":"10.1111\/j.1365-2990.1988.tb01139.x"},{"key":"key\n\t\t\t\t20170712063355_R26","doi-asserted-by":"crossref","unstructured":"Davies J, Everall IP, Weich S et al. HIV-associated brain pathology: a comparative international study. Neuropathol Appl Neurobiol1998;24: 118\u201324.","DOI":"10.1046\/j.1365-2990.1998.00096.x"},{"key":"key\n\t\t\t\t20170712063355_R27","unstructured":"Remington JS, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO (eds). Infectious Diseases of the Fetus and Newborn Infant. Philadelphia: WB Saunders, 1983, pp.143\u2013263."},{"key":"key\n\t\t\t\t20170712063355_R28","doi-asserted-by":"crossref","unstructured":"Chaisson RE, Moore RD, Richman DD, Keruly J, Creagh T. Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. Am Rev Respir Dis1992;146:285\u201389.","DOI":"10.1164\/ajrccm\/146.2.285"},{"key":"key\n\t\t\t\t20170712063355_R29","doi-asserted-by":"crossref","unstructured":"Low N, Pfluger D, Egger M, Swiss HIV Cohort Study. Disseminated Mycobacterium avium complex disease in the Swiss HIV Cohort Study: increasing incidence, unchanged prognosis. AIDS1997;11:1165\u201371.","DOI":"10.1097\/00002030-199709000-00013"},{"key":"key\n\t\t\t\t20170712063355_R30","doi-asserted-by":"crossref","unstructured":"Ledergerber B, Egger M, Erard V et al. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy. JAMA1999;282:2220\u201326.","DOI":"10.1001\/jama.282.23.2220"},{"key":"key\n\t\t\t\t20170712063355_R31","doi-asserted-by":"crossref","unstructured":"McNeil AJ, Gore SM. Statistical analysis of zidovudine (AZT) effect on CD4 cell counts in HIV disease. Stat Med1996;15:75\u201392.","DOI":"10.1002\/(SICI)1097-0258(19960115)15:1<75::AID-SIM142>3.0.CO;2-8"},{"key":"key\n\t\t\t\t20170712063355_R32","unstructured":"Lang W, Perkins H, Anderson RE, Royce R, Jewell N, Winkelstein W. Patterns of T-lymphocytes changes with human immunodeficiency virus infection from seroconversion to the development of AIDS. J Acquir Immun Defic Syndr1989;2:63\u201369."}],"container-title":["International Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ije\/article-pdf\/30\/4\/864\/18524987\/300864.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:33:07Z","timestamp":1704414787000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ije\/article-lookup\/doi\/10.1093\/ije\/30.4.864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2001,8]]},"published-print":{"date-parts":[[2001,8]]}},"URL":"https:\/\/doi.org\/10.1093\/ije\/30.4.864","relation":{},"ISSN":["1464-3685","0300-5771"],"issn-type":[{"value":"1464-3685","type":"electronic"},{"value":"0300-5771","type":"print"}],"subject":[],"published":{"date-parts":[[2001,8]]}}}